MARCHELLE LEEPER: Open Payments
NPI 1629369673 · MARS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,098 in 112 payments from 20 companies in 2025. Trend: 2023 $2,670 · 2024 $2,406 · 2025 $2,098
Food & beverage: $2,098
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $463 |
| Daiichi Sankyo Inc. | 13 | $283 |
| Novo Nordisk Inc | 17 | $281 |
| GlaxoSmithKline, LLC. | 11 | $211 |
| Lilly USA, LLC | 11 | $195 |
| Abbott Laboratories | 8 | $141 |
| Teva Pharmaceuticals USA, Inc. | 5 | $106 |
| PFIZER INC. | 5 | $98 |
| Lundbeck LLC | 2 | $54 |
| ACADIA Pharmaceuticals Inc | 2 | $47 |
Products named: INJECTAFER, QULIPTA, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, MOUNJARO, Wegovy, AUSTEDO XR, UBRELVY.
Industry payments across PA — which companies pay providers there.
